Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

13.5K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.5K
Emerging Adulthood01:27

Emerging Adulthood

686
Jeffrey Arnett's concept of emerging adulthood offers a framework to understand the unique developmental stage between adolescence and full-fledged adulthood, generally from ages 18 to 25. This period is marked by extensive exploration and shifts in identity, relationships, and career choices, a process known in psychology as role experimentation. Emerging adulthood reflects the evolving cultural expectations surrounding adulthood and the dynamic process of personal transformation during...
686
Relative Risk01:12

Relative Risk

2.1K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.1K
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

365
Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
365
Transcription Factors02:16

Transcription Factors

82.7K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.7K
Applications of GIS: Disaster Management and Emergency Response01:29

Applications of GIS: Disaster Management and Emergency Response

523
Geographic Information System (GIS) technology is essential for risk identification, action prioritization, and resource optimization in critical situations like flooding and earthquakes. By integrating spatial and demographic data, GIS provides a comprehensive framework for emergency response.GIS integrates data layers, like rainfall intensity, topography, elevation profiles, and river levels, to model high-risk flood zones. These layers assess areas susceptible to flooding based on their...
523

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lipoprotein apheresis in the era of new lipid-lowering therapies.

European heart journal·2026
Same author

Treatment of Clinically Diagnosed Alzheimer's Disease by External Counterpulsation A Randomized Clinical Trial.

American journal of Alzheimer's disease and other dementias·2026
Same author

It's time to test all adults for lipoprotein(a).

Journal of clinical lipidology·2026
Same author

Lipoprotein(a) and Women's Cardiovascular Health: A Review.

JACC. Advances·2026
Same author

Evinacumab with or without lipoprotein apheresis in homozygous familial hypercholesterolaemia.

European journal of preventive cardiology·2026
Same author

Addressing the Lp(a) hypothesis: will lowering Lp(a) decrease the risk of cardiovascular events?

Nature reviews. Cardiology·2026

Related Experiment Video

Updated: Feb 1, 2026

In Vitro Rearing of Solitary Bees: A Tool for Assessing Larval Risk Factors
08:50

In Vitro Rearing of Solitary Bees: A Tool for Assessing Larval Risk Factors

Published on: July 16, 2018

8.7K

JCL roundtable-Lipoprotein(a): The emerging risk factor.

Santica M Marcovina1, Patrick M Moriarty2, Marlys L Koschinsky3

  • 1University of Washington, Seattle, WA, USA.

Journal of Clinical Lipidology
|December 12, 2018
PubMed
Summary

Lipoprotein(a) (Lp(a)) is a key risk factor for cardiovascular events and calcific aortic stenosis. Emerging therapies show promise in significantly lowering Lp(a) levels, offering new clinical strategies.

Keywords:
AtherothrombosisCalcific aortic stenosisCardiovascular riskChildhood strokeLipoprotein(a)

More Related Videos

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

12.5K
Isolation of High-density Lipoproteins for Non-coding Small RNA Quantification
10:39

Isolation of High-density Lipoproteins for Non-coding Small RNA Quantification

Published on: November 28, 2016

11.8K

Related Experiment Videos

Last Updated: Feb 1, 2026

In Vitro Rearing of Solitary Bees: A Tool for Assessing Larval Risk Factors
08:50

In Vitro Rearing of Solitary Bees: A Tool for Assessing Larval Risk Factors

Published on: July 16, 2018

8.7K
Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

12.5K
Isolation of High-density Lipoproteins for Non-coding Small RNA Quantification
10:39

Isolation of High-density Lipoproteins for Non-coding Small RNA Quantification

Published on: November 28, 2016

11.8K

Area of Science:

  • Cardiovascular Medicine
  • Genetics
  • Pharmacology

Background:

  • Lipoprotein(a) (Lp(a)) is a significant risk factor for atherothrombotic events, comparable to LDL cholesterol.
  • Lp(a) is implicated in the progression of calcific aortic stenosis and arterial strokes, even without atherosclerosis.
  • Understanding Lp(a) inheritance and apolipoprotein(a) structure-function is advancing.

Purpose of the Study:

  • To review the role of Lipoprotein(a) in cardiovascular diseases.
  • To explore the interaction between Lp(a), oxidized phospholipids, and inflammatory markers.
  • To discuss novel pharmaceutical strategies for Lp(a) reduction and clinical management.

Main Methods:

  • Review of current literature on Lp(a) genetics, function, and clinical impact.
  • Discussion of recent findings on Lp(a) interactions with inflammatory pathways.
  • Analysis of emerging antisense and RNA interference technologies for Lp(a) lowering.

Main Results:

  • Lp(a) levels are strongly inherited, with apolipoprotein(a) structure influencing function.
  • Interactions between oxidized phospholipids on Lp(a) and interleukin-1 genotypes are observed.
  • New therapies, including antisense and RNA interference, can reduce Lp(a) by up to 90%.

Conclusions:

  • Lipoprotein(a) is a critical, actionable target for cardiovascular risk reduction.
  • Novel therapeutic approaches offer unprecedented potential for lowering Lp(a) levels.
  • Clinical measurement and management strategies for Lp(a) are evolving.